Product Information
ATROPINE 1% EYE DROPS is a generic product labeled by NorthStar Rx LLC, priced at $5.1339 per ML under NDC 72603026402. Its NADAC has been published 92 times since Jan 1, 2025.
FDA first approved this application on Jan 8, 2024. Its Orange Book therapeutic-equivalence code is AT1.
Strength
10 mg/mL
Manufacturer
NorthStar Rx LLCNDC
72603026402
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
ATROPINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA218148FDA Approved
1/8/2024
TE Code
AT1
On Market Since
9/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ATROPINE 1% EYE DROPS has been published 92 times since Jan 1, 2025, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.1339 per ML |
|---|---|
| All-time high | $7.1376 (May 14, 2025) |
| All-time low | $5.1339 (Sep 23, 2026) |
| 52-week high | $6.9560 |
| 52-week low | $5.1339 |
| Median price | $6.6909 |
| Average price | $6.4334 |
| Largest weekly change | +14.6% (Feb 19, 2025) |
| Weeks tracked | 92 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atropine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATROPINE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ATROPINE 1% EYE DROPS, manufactured by NorthStar Rx LLC, is $5.1339 per ML (NDC 72603026402), effective Sep 30, 2026.
How has the price of ATROPINE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ATROPINE 1% EYE DROPS has declined 9.9%. It has been tracked across 92 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for ATROPINE 1% EYE DROPS?
Since Jan 1, 2025, the NADAC for ATROPINE 1% EYE DROPS has ranged from a low of $5.1339 (Sep 23, 2026) to a high of $7.1376 (May 14, 2025), with a median of $6.6909 per ML.
Are there cheaper alternatives to ATROPINE 1% EYE DROPS?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATROPINE 1% EYE DROPS, is $4.1619 per ML — about 19% below ATROPINE 1% EYE DROPS.
Who manufactures ATROPINE 1% EYE DROPS?
ATROPINE 1% EYE DROPS (NDC 72603026402) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.